ApprovalTrail

Approval · Notice of Compliance 7883 · 2006

CYCLOMEN: Notice of Compliance 7883

Issued April 18, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7883
Date
April 18, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Pituitary gonadotropin inhibitor

Products in this notice

BrandDINStatus today
CYCLOMEN02018144Cancelled Post Market
CYCLOMEN02018152Marketed
CYCLOMEN02018160Marketed

Medicinal ingredients